Genmab share buy-back program expected to be completed by December

On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares.

The share buy-back program is expected to be completed no later than December 16, 2024.

The following transactions were executed under the program from April 8, 2024 to April 12, 2024:

Details of each transaction are included as an appendix to this announcement.

Following these transactions, Genmab holds 1,129,976 shares as treasury shares, corresponding to 1.71% of the total share capital and voting rights.

The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Further details on the terms of the share buy-back program can be found in our company announcement no. 22 dated March 15, 2024.
MB Bureau